These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Major bleeding and severe thrombocytopenia after combined heparin and abciximab-c7E3 Fab therapy. Claeys LG; Berg W Eur J Vasc Endovasc Surg; 2003 Jan; 25(1):85-7. PubMed ID: 12525818 [No Abstract] [Full Text] [Related]
5. Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature. Makoni SN Heart; 2001 Dec; 86(6):E18. PubMed ID: 11711483 [TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Curtis BR; Swyers J; Divgi A; McFarland JG; Aster RH Blood; 2002 Mar; 99(6):2054-9. PubMed ID: 11877279 [TBL] [Abstract][Full Text] [Related]
11. Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy. Reddy MS; Carmody TJ; Kereiakes DJ Catheter Cardiovasc Interv; 2001 Apr; 52(4):486-8. PubMed ID: 11285605 [TBL] [Abstract][Full Text] [Related]
12. Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. Curtis BR; Divgi A; Garritty M; Aster RH J Thromb Haemost; 2004 Jun; 2(6):985-92. PubMed ID: 15140135 [TBL] [Abstract][Full Text] [Related]
13. Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro). Sharma S; Bhambi B; Nyitray W; Sharma G; Shambaugh S; Antonescu A; Shukla P; Denny E J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):21-4. PubMed ID: 12000974 [TBL] [Abstract][Full Text] [Related]
15. Delayed immune-mediated thrombocytopenia after re-exposure to abciximab therapy. Rasti M; Blostein M Can J Cardiol; 2011; 27(6):869.e13-4. PubMed ID: 21885241 [TBL] [Abstract][Full Text] [Related]
16. Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration. Webb GJ; Swinburn JM; Grech H Platelets; 2011; 22(4):302-4. PubMed ID: 21526887 [TBL] [Abstract][Full Text] [Related]
17. Severe thrombocytopenia after an infusion of abciximab. Rubio A; González C; Majado MJ; Salido E; García-Candel F; González-Carrillo J Haematologica; 2001 Mar; 86(3):E05. PubMed ID: 11255292 [No Abstract] [Full Text] [Related]
18. Understanding the complexity of abciximab-related thrombocytopenia. De Caterina R; Zimarino M Thromb Haemost; 2010 Mar; 103(3):484-6. PubMed ID: 20135055 [No Abstract] [Full Text] [Related]
19. Delayed profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Jenkins LA; Lau S; Crawford M; Keung YK Circulation; 1998 Mar; 97(12):1214-5. PubMed ID: 9537353 [No Abstract] [Full Text] [Related]
20. Thrombocytopenia associated with c7E3 Fab (abciximab). Schell DA; Ganti AK; Levitt R; Potti A Ann Hematol; 2002 Feb; 81(2):76-9. PubMed ID: 11907786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]